Table of content for "Brexucabtagene autoleucel ca" (HCPCS C9073)
General information on the “C9073” code
HCPCS Code: C9073
Long Description: Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Short Description: Brexucabtagene autoleucel ca
Original information is taken from C9073 page
Pricing indicators
Pricing Indicator Code 1: 53 – Statute
Multiple Pricing Indicator Code A : Not applicable as HCPCS priced under one methodology
Certification and additional reference information
Statute Number: 1833(T)
Cross Reference Code 1: Q2053 ;
Coverage
Coverage: D – Special coverage instructions apply
Type of service
Berenson-Eggers Type of Service (BETOS): O1E – Other drugs
Type Of Service 1: 9 – Other medical items or services
Type Of Service 2: F – Ambulatory surgical center (facility usage for surgical services)
Misc information
Anesthesia Base Unit Quantity: 0
Code Added Date: 20210101
Code Effective Date: 20210401
Termination Date: 20210331
Action Code: N – No maintenance for this code